Join us for our first U.S.-based Women’s Life Sciences Network event in Cambridge, a center of life sciences and technology. Keynote speaker Lara Sullivan, President and CEO of Pyxis Oncology, will share and discuss hot topics in the industry – followed by a networking reception with cocktails and hors d'oeuvres. Click here to join the Women’s […]
Building a foundation for success in the medical products industry Join us for an afternoon of discussions designed to provide a foundation in FDA, healthcare, and securities issues arising in the development of medical products. Whether you are relatively new to counseling and risk mitigation in these areas or more experienced counsel looking for an […]
Digital Health and Artificial Intelligence: Drivers in Transforming the Life Sciences Industry Join us in Zürich for our next Women’s Life Sciences Network event, which will feature a panel discussion with leading life sciences industry women about the use of artificial intelligence and digital health. Moderated panel discussion: Data augmenting in healthcare Challenges and opportunities […]
Please save the date for a digital health-focused roundtable hosted by Sidley and The Digital Therapeutics Alliance on Wednesday, May 10. Across two panels, we will discuss important and timely topics including marketing pathways, coverage and reimbursement issues, and more.
Please join Sidley for the Boston Life Sciences Roundtable, an afternoon of provocative discussions addressing cutting-edge trends and hot topics. FEATURED PANELS Please see below for discussion topics during the Boston Life Sciences Roundtable: Leading Life Sciences Companies: A Conversation with Boston Area Life Sciences General Counsel Ty Howton, Chief Administrative Officer and Secretary, Solid […]
Join us in Brussels for our next Women’s Life Sciences Network event, which will feature a special address by Ruta Janeckaite (European Commission). The discussion will include: Status of the Commission’s preparation and tasks ahead Regulatory opportunities Industry implementation path A Q&A session will follow the moderated discussion. 6:00 p.m. CET The panel discussion will be […]
Please join Sidley for a networking event during BIO 2023. Connect with fellow biotech and pharma colleagues and engage in discussion about industry trends and learnings from BIO. RSVP Here Please RSVP by Friday, May 26. The health of our clients, colleagues, and guests is important to us. If you are experiencing cold or flu-like […]
Please join Sidley for the Bay Area Lifesciences Roundtable, an afternoon of provocative discussions addressing cutting-edge trends and hot topics. Featured Panels Getting Approved: Creative Approaches to Ensuring Regulatory Success in New Product Development Lisa Taylor Ash, General Counsel, Shape Therapeutics Maryam Khotani, Associate General Counsel, Practice Group Leader, Genentech Michael Listgarten, General Counsel, RAPT Therapeutics Joel […]
With deal and investment activity remaining critical for the success of the life sciences and healthcare industry, Sidley is bringing together senior pharma, biotech, healthcare, private equity, and venture capital leads to provide their insights on key topics, trends, and opportunities. RSVP Here Join Sidley and industry leaders from across the globe for this in-person, […]
Join Sidley at our annual Boston Life Sciences Roundtable for an afternoon of engaging discussion addressing cutting-edge trends and hot topics. 1:30 p.m. Registration | 2:00 p.m. Program | 5:00 p.m. Reception For more information, contact bosevents@sidley.com. FEATURED PANEL TOPICS I Used To Practice Law: A Conversation with Life Sciences Leaders A rare few life sciences […]
Join us for an engaging and informative panel discussion on life sciences disputes as part of ICCA 2024 Hong Kong. Our panel comprising Sidley disputes and life sciences specialists as well as inhouse counsel will explore (i) general trends in life sciences transactions, (ii) the complexities and unique challenges involved in life sciences disputes with […]
After several years of relatively little enforcement, FDA has recently been flexing its muscles in the promotion area. The Office of Prescription Drug Promotion (OPDP) in particular has issued several notable warning and untitled letters in the past year, representing an increased volume in enforcement and increased scrutiny of efficacy claims. This includes more rigorous […]
